DOCSLIB.ORG

LOYCE PACE Global Health Council | @Globalgamechngr | [email protected] Loyce Is an Outspoken Advocate on Global Health Issues from AIDS to Zika

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
LOYCE PACE Global Health Council | @Globalgamechngr | Hogbasion@Globalhealth.Org Loyce Is an Outspoken Advocate on Global Health Issues from AIDS to Zika 100 WOMEN EXPERTS WORKING IN HEALTH SECURITY Gender equality makes global health stronger. Join Women in Global Health and Women of Color Advancing Peace and Security in supporting equitable representation in global health security decision-making. Use this roster Representation matters. As outbreaks and epidemics 2) miss out on the gender dimensions of health continue to remind us, women face greater risks because emergencies, including the role of women in health they are the majority of frontline health workers, are care provision, the differences in disease transmission typically the primary caregivers of the sick, and have and outcomes between the sexes, and gender-based greater socioeconomic vulnerability. Yet, few women are disparities in the way the sick seek medical care included in health security decision-making or quoted in 3) are more likely to overlook the wider consequences the media. In January 2020, just five women were invited of epidemics on reproductive, maternal and child to join the WHO Emergency Committee on COVID-19, health, such as lack of access to maternal and making up less than a quarter of the 21-member group. neonatal care, feminine hygiene products and And a recent presidential tweet showed the inaugural U.S. contraception products Coronavirus Task Force was comprised entirely of men. 4) miss out on leveraging the vast networks of women in affected countries who are part of the solution to Ratio (men:women) quoted containing the virus. in media in the past month in 3:1 response to #COVID19 Women in Global Health and Women of Color Advancing Peace and Security are working to change this disconnect between vulnerability and representation In failing to give women a seat at the decision-making in health security. This roster of expert women includes table, governments and international agencies trying to those who are working to strengthen global, regional, solve crises like COVID-19: national, and local capacities to prevent, detect, and 1) miss out on critical expertise because they aren’t respond to outbreaks. leveraging the entire global health security talent pool 1 The voices of diverse women experts add value to any global health security decision-making body, as well as to media coverage of emerging threats such as COVID-19. OUR ROSTER OF WOMEN HEALTH SECURITY EXPERTS Operation 50/50 nominations are accepted on a REPRESENTS A DIVERSE GROUP OF TALENTED WOMEN rolling basis and this list will be regularly updated – at womeningh.org. Are you a woman working in health • Experts are drawn from all over the world, and specialize security or do you know another woman working in this in a variety of security-related global health fields space? Are you a man with female colleagues you want to • Over thirty countries are represented, from all regions of elevate? the world NOMINATE HERE: http://bit.ly/WGHSecurity • Over a quarter self-identify as Women of Color. Contact us at [email protected] with any questions. # Women Health Security Experts ALINA AKHYAR International Rescue Committee | @RonaqeQainaat Program Manager Pakistan (MoM) and now as a Team Leader GAVI’s CSOs Coalition for Health and Immunization – Pakistan (PCCHI) 1 CEO and founder of Ronaq-e-Qainatt. Through Ronaq-e-Qainaat she has been directly involved in conducting hundreds of free medical camps all over Pakistan especially in disaster stuck areas but most of all conducting various free health awareness campaigns for the under privileged community highlighting issues like importance of MnCH, hygiene, importance of RI and many other relevant themes. Identity/Nationality: Woman of Color (South Asian)/Pakistan. Years of experience: 11+ HEIDI ALBERT FIND Foundation for Innovative New Diagnostics [email protected] | https://www.linkedin.com/in/heidi-albert-17373767/ Dr Heidi Albert obtained a Bachelor of Pharmacy and Pharmacology Honours degree and PhD at the University of Bath, UK, before moving into a research career in diagnostics. She has more than 20 years of experience in TB diagnostics development and implementation in low resource settings. She completed a Masters of Public Health, specializing in Health Economics, at the University of Cape Town. Heidi joined FIND in 2007 to oversee demonstration projects for rapid screening of multidrug-resistant TB in South Africa. In 2008 she moved to Uganda to establish FIND’s Diagnostics Research Laboratory based at the National TB Reference Laboratory in Kampala, and conducted studies aimed at improving and simplifying specimen processing, as well as clinical studies of new technologies, including LED fluorescence microscopy, line probe assays and Xpert MTB/RIF. From 2012-2016 she was the Principal 2 Investigator for FIND’s CDC-funded Cooperative agreement, “Building Global Capacity for Diagnostic Testing of Tuberculosis, Malaria and HIV through Laboratory Strengthening and Integration of Services under the President’s Emergency Plan for AIDS Relief (PEPFAR operating in 13 countries in Africa, Asia and the Caribbean. She served on the Core Group of the Global Laboratory Initiative, a working group of the Stop TB Partnership from 2014-2018 and on the GLI Africa regional core group, and has been a lead contributor to multiple global and national TB diagnostic guidelines and tools. She currently leads work on Networks for Optimized Diagnosis (NODE), a data-driven network design approach to inform national strategic planning and donor investments, including development of open access software for use across multiple diseases. Expert in Covid-19 Diagnostics, Diagnostics development and implementation in low-resource settings, Diagnostic network design and optimization, Rapid screening, Phage-Based Assays, LED fluorescence microscopy, line probe assays and Xpert MTB/RIF, TB, HIV, and Laboratory set up, Laboratory strengthening, training, quality assurance and quality management systems. Identity/Nationality: UK. Years of experience: 20+ 2 # Women Health Security Experts HALEEMA ALSEREHI Saudi Center for Disease Prevention and Control 3 @Alserehi_h | [email protected] Infectious Diseases/Infection Control/Hospital epidemiologist. Identity/Nationality: Saudi Arabia Years of experience: 6 JENNYFER AMBE The GET Consortium / WCAPS | @JennyferAmbe | [email protected] 4 Expert in Global public health, Emerging Infectious Diseases, Bioethics, Biosecurity, Community Engagement in the Sahel and Lake Chad region, Gender Equity. Identity/Nationality: Woman of Color/Nigeria. ASHLEY ARABASADI Management Sciences for Health | @al_arabasadi | [email protected] Health Security Policy Advisor for Management Sciences and Health and former Chair of the Global Health Security Agenda Consortium. Global health security, policy and advocacy, stakeholder 5 engagement, civil society, social and cultural anthropology, humanitarian and emergency response, government affairs. Led the Global Health Security Agenda Consortium from 2017-2019 and during that time we successfully obtained a permanent seat for civil society and non-governmental stakeholders at the Global Health Security Agenda Steering Committee through 2024. Identity/Nationality: USA. Years of experience: 15 SULZHAN BALI Health Security / World Bank | @sulzhan | [email protected] 6 Expert in Pandemic Preparedness, Health Security, Global Health Governance, Gender and Epidemics, Disease Surveillance and Response Systems, Fear-based Aversion behavior, Emergency Response, Biomedical Sciences, One Health, and Public Health. Identity/Nationality: Woman of Color/India. Years of Experience: 12 JULIA BARNES-WEISE Duke University / CEPI | @barnes_weise 7 Lawyer, global health policy consultant, and entrepreneur. Executive Director, Global Healthcare Innovation Alliance Accelerator at Duke University. Senior Consultant to the Coalition for Epidemic Preparedness Innovations (CEPI). ADIA BENTON Northwestern University | @Ethnography911 8 American cultural and medical anthropologist. Militarization and Securitization During West Africa’s Ebola Outbreak. Identity/Nationality: Woman of Color 3 # Women Health Security Experts NAHID BHADELIA Boston University SCHOOL OF MEDICINE 9 @BhadeliaMD | [email protected] Infectious diseases physician and the medical director of Special Pathogens Unit at Boston University School of Medicine. Identity/Nationality: Woman of color. Years of Experience: 10 PAURVI BHATT Medtronic Foundation | @PaurviBhatt | [email protected] 10 Expert in Health Policy and Financing, with experience in public-private partnerships, HIV/AIDS and non- communicable diseases. Identity/Nationality: Woman of Color (South Asia). Years of experience: 30 CATHARINA BOEHME FIND Foundation for Innovative New Diagnostics @BoehmeCatharina | [email protected] Dr Catharina Boehme has been CEO of FIND since 2013, previously holding positions as Chief Medical Officer and head of the organization’s tuberculosis (TB) programme. She has been responsible for the clinical evaluation of new tools for the diagnosis of TB, malaria and neglected diseases, as well as activities to enhance access to critical diagnostics, including laboratory strengthening, in-country validation, and implementation. Catharina has managed R&D projects for several new point-of-care technologies and molecular diagnostic approaches. She is a member of the WHO Strategic Advisory 11 Group of Experts on In Vitro Diagnostics (SAGE IVD), as well as sitting on several other WHO/UN boards. She is also a Lancet Commissioner for TB and Precision Global Health, and Co-chair of the New
Load more

Recommended publications
  • Compendium of the Findings of the OPCAST Pandemic Subgroup 12
    1 A Compendium of the Findings of the Obama PCAST Ad Hoc Subgroup on Pandemic Preparedness and Response December 23, 2020 Introduction A subset of the former members of President Obama’s Council of Advisors on Science and Technology (here OPCAST)—ten individuals who played particularly important roles in producing the six OPCAST reports between 2009 and 2016 that dealt with issues related to pandemic preparedness and response1—came together starting in March of this year to consider how insights from those studies might be combined with more recent research and current observations to develop suggestions about how the U.S. response to the COVID-19 pandemic could be improved. The Subgroup has produced six reports, addressing • the national strategic pandemic-response stockpile (May 20) • the role of contact tracing (June 18) • the role of public health data in controlling the spread of COVID-19 (July 28) • testing for the pathogen (August 18) • recommendations for the coming COVID-19 commission (September 21) • needs for improved epidemiological modeling (September 28) Each report was distributed, upon completion, to selected members of the Trump COVID-19 team and the Biden campaign staff, selected governors and members of Congress, selected public health experts outside government, and the media. The reports have also been posted on the OPCAST team’s website, http://opcast.org, together with a few opinion pieces based on them. In the current volume, we have assembled all six reports in full, preceded by a set of brief summaries. Four of the reports are followed by short updates taking account of developments since the reports first came out.
    [Show full text]
  • Principais Vozes Da Ciência No Twitter
    Principais vozes da ciência no Twitter: Mapeando a conversa de cientistas e especialistas sobre a COVID-19 UMA ANÁLISE DA REDE DE INTERAÇÕES NO TWITTER 1 O Science Pulse é uma ferramenta gratuita de social O Instituto Brasileiro de Pesquisa e Análise de Dados é um listening criada para preencher a lacuna entre jornalistas e centro independente de pesquisa e formação de analistas e cientistas. O objetivo é ajudar jornalistas a encontrar pesquisadores nas áreas de Pesquisa, Opinião Pública e conteúdos científicos que são tendência nas redes sociais e Comunicação Digital. a conhecer novos especialistas. O foco do Instituto é a aplicação e o ensino de técnicas e Com um algoritmo próprio, facilita a descoberta das metodologias de análise de dados com sólida formação publicações com maior popularidade dentro da comunidade científica para atuação no mercado. científica, das principais hashtags utilizadas e de perfis interessantes com menor engajamento. Conheça a nossa formação em Data Intelligence com curso exclusivo sobre Análise de Redes! O projeto foi criado pelo Volt Data Lab, agência do ICFJ Knight Fellow Sérgio Spagnuolo, e conta com apoio institucional da Agência Bori. 2 EXPEDIENTE Pesquisador Responsável Pedro Meirelles Coleta dos dados Science Pulse Tratamento dos dados IBPAD - Instituto Brasileiro de Pesquisa e Análise de Dados COMO CITAR? MEIRELLES, Pedro. Principais vozes da ciência no Twitter: Mapeando a conversa de cientistas e especialistas sobre a COVID-19. Relatório. Instituto Brasileiro de Pesquisa e Análise de Dados (IBPAD): Brasília, 2020. 3 METODOLOGIA A rede de interações foi desenvolvida a partir da base de dados do Science Pulse, que reuniu 213.469 publicações de cientistas, especialistas e organizações da comunidade científica sobre a SOBRE O RELATÓRIO COVID-19 entre junho e outubro de 2020.
    [Show full text]
  • Legal-Graphics' 2-19-21 COVID Timeline
    Number of days Overview: Year 2 of COVID since first sign of virus Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Link to Source over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 Signs of Virus 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 Key Events Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Good News! Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map shows its vaccine 1st rapid virus test 12 million ... spread economy is Christmas trees emergency states with the huge vaccination number of deaths OK’d in days - and Moderna US nursing homes and Moderna the world prevent COVID-19 which countries were developed by county showing Legal Matters is more than that gives results 'faster' and 'broader' worrisome skyrockets amid authorization their highest number plan watched by country (by “normal” next fall vaccines work? vaccines compare infection have rolled out so quickly risk for COVID 94% effective at home than ever as virus toll of virus coronavirus vaccine of virus deaths by the world number of days in those exposed? a COVID-19 vaccine inflicts damage since 100 deaths Dec.
    [Show full text]
  • Emerging Leaders in Biosecurity Initiative
    Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles.
    [Show full text]
  • National Covid-19 Testing & Tracing Action Plan
    National Covid-19 Update Report Testing & Tracing Time to Redouble Our Efforts on Action Plan Covid-19 Testing Embargoed until 12:01am EDT, Thursday, July 16, 2020 THE ROCKEFELLER FOUNDATION NATIONAL COVID-19 TESTING & TRACING ACTION PLAN 1 This terrifying tragedy was not and is not inevi- Foreword table. America can function safely, even as we fight Covid-19. Other countries have shown that a better alternative is possible. But as we said in America faces an impending disaster. April – when we first released The Rockefeller Foundation’s National Covid-19 Testing Action The extraordinary scale of the Plan – testing is the only way out of our present disaster, and it will remain the case until a vaccine Covid-19 crisis is evident in the or effective therapeutics are widely available. growing deaths and economic losses When we were barely a month into this pan- the pandemic has wrought in every demic, we brought together scientists, industry, technologists, economists, and Republicans state. Devastated minority and and Democrats alike to formulate an action plan low-income families bore the brunt of to expedite the development of our nation’s widespread testing and tracing system. We those costs. As the virus tore across called for rapidly expanded diagnostic test- ing capacity from 1 million tests per week to 3 the country, it exposed the structural million tests per week by June, and to 30 million inequities that have underpinned tests per week by October. Today we’re at 4.5 million tests per week, but unfortunately it’s and undermined our economy taking far too long to get to 30 million tests per week, and communities that most need them – for decades.
    [Show full text]
  • May 13 Federal Update
    Congressional and Federal Agency Responses and Opportunities Regarding the COVID-19 Outbreak Lewis-Burke Associates LLC May 13, 2020 Table of Contents Introduction ................................................................................................................................................. 3 Congressional and Federal Updates ............................................................................................................. 3 Update: Democrats Unveil Proposed $3 Trillion Response Package ........................................................ 3 Update: House, Senate Committees Hold Hearings on COVID-19 Response ........................................... 9 Federal Guidance Related to Research and Higher Education ................................................................... 10 Office of Management and Budget (OMB) ............................................................................................ 10 Update: Department of Education (ED) ................................................................................................. 12 National Institutes of HealtH (NIH) ......................................................................................................... 15 Department of HealtH and Human Services (HHS) ................................................................................. 16 Centers for Medicare and Medicaid Services (CMS) .............................................................................. 16 Food and Drug Administration (FDA) ....................................................................................................
    [Show full text]
  • IHP News 559 : “Public Enemy Number One”
    IHP news 559 : “Public enemy number one” ( 14 February 2020) The weekly International Health Policies (IHP) newsletter is an initiative of the Health Policy unit at the Institute of Tropical Medicine in Antwerp, Belgium. Dear Colleagues, I know, I know, it’s Valentine today, so I probably shouldn’t talk about the eerily sounding “Covid- 19” in this short intro, let alone about the even more dreaded “P word” but WHO and dr. Tedros were clearly in no mood for Valentine earlier this week, when describing the virus as “a global threat, potentially worse than terrorism”. “The world must wake up and consider this enemy virus as public enemy number one,” Tedros said. With world media and public opinion going berserk all around the world for a few weeks now, I think that shouldn’t be too much of a problem. The other part of his message, however, that it’s about "solidarity, solidarity and solidarity", might prove much harder in the weeks and months to come, given how Sapiens is wired. When thinking of pandemics, in this visual culture of ours, we probably all have (subconsciously or not) a particular movie in mind when considering some of the most dire scenarios. For some of you, that might be “Contagion”, for me, it’s no doubt “Twelve Monkeys” (1995), with among others, Bruce Willis, a stunning Madeleine Stowe and a young Brad Pitt. Back in the innocent ‘90s, it all felt a bit surreal, even the obligatory rogue scientist popping up towards the end. But what a great movie! Now in the year 2020, with the scary ongoing public health experiment (aka ‘the coronavirus cruise ship quarantines’), occasionally I get the feeling that “Twelve Monkeys” is being mixed up with “the Poseidon Adventure” .
    [Show full text]
  • Corman-Drosten Review Report
    Healthy Gallatin From: Owen Giddings <[email protected]> Sent: Wednesday, February 3, 2021 3:30 PM To: BOHPublicComment Subject: Vaccination rates Categories: NonAgendaPC Could the Health Board please speak in concrete terms to why Gallatin County is lagging significantly behind all of Montana's other large cities in vaccination rates, per the Montana Covid dashboard? First shots administered: as of 2/3: Missoula Count (Missoula): 12.9% vaccinated Lewis and Clark County (Helena): 14.4% vaccinated Yellowstone County (Billings): 14.6% vaccinated Cascade County (Great falls): 12.8% vaccinated Gallatin County: 8.1% vaccinated Silver Bow County (Butte): 17.7% vaccinated 1 Healthy Gallatin From: Administrator <[email protected]> Sent: Wednesday, February 3, 2021 1:29 PM To: BOHPublicComment Subject: mask mandate Categories: NonAgendaPC BOH members and staff, I continue to be dismayed at the lack of enforcement of the mask order in commercial establishment in Bozeman. The BOH inclusion of an exemption for medical reasons provides an illogical loophole big enough for the Queen Mary. Nobody with an actual respiratory health issue is going to be maskless out in public and run the risk of encountering some asymptomatic anti‐masker. Responsible businesses include an option for curbside service for those who don’t want to comply with the mask requirement. The choice to enter a business includes the responsibility to adhere to the safety policies of that business. Smoking or going naked are not tolerated by businesses, going maskless shouldn’t be either. Employees maybe exposed to scores or hundreds of customers each day. Gallatin County’s positivity rate all but insures that the typical service industry employee will encounter people who are infected.
    [Show full text]
  • The Diocese of Southeast Florida's Reopening
    On Being Faithful Guidelines for a Shared Discernment on the Way Ahead in this Season of COVID-19 But now thus says the Lord, he who created you, O Jacob, he who formed you, O Israel: Do not fear, for I have redeemed you; I have called you by name, you are mine. For I am the Lord your God, the Holy One of Israel, your Savior. Do not remember the former things, or consider the things of old. I am about to do a new thing; now it springs forth, do you not perceive it? I will make a way in the wilderness and rivers in the desert. [Isaiah 43:1,3,18-19] Preface Little did we know when the forty days of Lent began, that we would end the season in quarantine, either self-imposed, as if in a kind of strict Lenten fast, or enforced by guidelines promoted to protect public health and safety. From the forty (Latin: quaranta) days of Lent we have passed through the remembrance of Christ’s saving death and glorious resurrection into the fifty days of the Easter season, sure that Jesus Christ is risen, but still wondering when it might be safe for us to emerge from our own ‘tombs’ into the light of a new day. The new day has come, but we would do well to acknowledge that it is of a different kind and order, and one which no longer holds any certainty in this COVID-19 world. In this unwelcome season of the COVID-19 virus, we find ourselves living through a period of volatility, uncertainty, complexity, and ambiguity, or, for short, a VUCA season.
    [Show full text]
  • Written Testimony As
    United States House of Representatives Committee on Science, Space and Technology Subcommittee on Investigations and Oversight COVID-19 Variants and Evolving Research Needs May 12, 2021 Caitlin Rivers, PhD, MPH Senior Scholar, Johns Hopkins Center for Health Security Assistant Professor, Environmental Health and Engineering Johns Hopkins Bloomberg School of Public Health Current situation In the United States, we have entered a new phase of the pandemic. Nearly 60% of American adults have begun vaccination, including more than 80% of adults over age 65. Community transmission is declining, and I believe that by summer we will be able to resume most normal activities. However, in the last 14 months over 575,000 Americans have died and 32 million cases have been reported, with more likely unrecognized. Beyond the direct impacts, we have also endured severe economic consequences, disruption to education, strain on our healthcare systems, and we have missed time with loved ones. We have collectively suffered an enormous loss, and that grief will not be easily overcome. The toll of this pandemic is profound. The situation in some other countries is much worse, and the pandemic is far from over. Case counts are reaching new highs, with some recent days exceeding 800,000 reported cases and 13,000 deaths. India is in the midst of a terrible wave, and reports suggest that in some communities the situation is dire. A variant of interest, B.1.617, may be contributing to the surge. As our own domestic outbreak improves, we must turn our attention to helping the world. As we continue the work of ending the pandemic both at home and around the world, we must also identify the changes necessary to ensure we are never in this position again.
    [Show full text]
  • 2Nd Wave of Virus Cases? Experts Say We're Still in the 1St 21 June 2020, by Mike Stobbe
    2nd wave of virus cases? Experts say we're still in the 1st 21 June 2020, by Mike Stobbe wave before you have a second wave." Clearly there was an initial infection peak in April as cases exploded in New York City. After schools and businesses were closed across the country, the rate of new cases dropped somewhat. But "it's more of a plateau, or a mesa," not the trough after a wave, said Caitlin Rivers, a disease researcher at Johns Hopkins University's Center for Health Security. Scientists generally agree the nation is still in its first wave of coronavirus infections, albeit one that's dipping in some parts of the country while rising in The daily count of new coronavirus cases in the U.S. is others. on the rise, fueled by a surge of new cases in the South and West and efforts to restart the economy.; "This virus is spreading around the United States and hitting different places with different intensity at different times," said Dr. Richard Besser, chief executive of the Robert Wood Johnson Foundation What's all this talk about a "second wave" of U.S. who was acting director of the Centers for Disease coronavirus cases? Control and Prevention when a pandemic flu hit the U.S. in 2009. In The Wall Street Journal last week, Vice President Mike Pence wrote in a piece headlined Dr. Arnold Monto, a University of Michigan flu "There Isn't a Coronavirus 'Second Wave'" that the expert, echoed that sentiment. nation is winning the fight against the virus.
    [Show full text]
  • MERS Coronavirus: Diagnostics, Epidemiology and Transmission Ian M
    Mackay and Arden Virology Journal (2015) 12:222 DOI 10.1186/s12985-015-0439-5 REVIEW Open Access MERS coronavirus: diagnostics, epidemiology and transmission Ian M. Mackay1,2,3* and Katherine E. Arden2 Abstract The first known cases of Middle East respiratory syndrome (MERS), associated with infection by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively. The case first to be publicly reported was from Jeddah, in the Kingdom of Saudi Arabia (KSA). Since then, MERS-CoV sequences have been found in a bat and in many dromedary camels (DC). MERS-CoV is enzootic in DC across the Arabian Peninsula and in parts of Africa, causing mild upper respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections. Precisely how virus transmits to humans remains unknown but close and lengthy exposure appears to be a requirement. The KSA is the focal point of MERS, with the majority of human cases. In humans, MERS is mostly known as a lower respiratory tract (LRT) disease involving fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 % to 40 % of those infected. However, MERS-CoV has also been detected in mild and influenza-like illnesses and in those with no signs or symptoms. Older males most obviously suffer severe disease and MERS patients often have comorbidities. Compared to severe acute respiratory syndrome (SARS), another sometimes- fatal zoonotic coronavirus disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in patients with underlying disease and is more often fatal.
    [Show full text]